ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,691Medicare Part D Prescriptions Filled, Including Refills

Rank: 581 out of 3734

$531K Total Retail Price of All Prescriptions

Rank: 641 out of 3734

769 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 769 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 769 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 7,023 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
LEVOTHYROXINE SODIUM 416 331 1 2
LISINOPRIL 332 248 2 3
SIMVASTATIN 316 273 3 1
METFORMIN HCL 275 209 4 8
FUROSEMIDE 248 152 5 7
WARFARIN SODIUM 242 208 6 10
AMLODIPINE BESYLATE 219 183 7 5
CARVEDILOL 202 149 8 30
OMEPRAZOLE 181 145 9 4
HYDROCODONE-ACETAMINOPHEN 162 46 S3 10 12
TRAMADOL HCL 157 80 11 20
METOPROLOL TARTRATE 149 136 12 6
NEXIUM 138 89 13 36
HYDROCHLOROTHIAZIDE 133 106 14 9
CITALOPRAM HBR 129 110 15 16
GABAPENTIN 127 68 16 17
LOSARTAN POTASSIUM 126 108 17 21
ATENOLOL 116 97 18 13
POTASSIUM CHLORIDE 106 83 19 19
PRAVASTATIN SODIUM 105 79 20 15
ATORVASTATIN CALCIUM 88 62 21 11
CLOPIDOGREL 86 76 22 23
MIRTAZAPINE 77 42 23 45
SPIRIVA 74 65 24 40
METOPROLOL SUCCINATE 74 60 24 14
ALLOPURINOL 73 53 26 33
RANITIDINE HCL 73 55 26 32
JANUVIA 71 64 28 50
DIGOXIN 66 56 29 43
LOVASTATIN 65 59 30 41
ADVAIR DISKUS 65 42 30 35
VENLAFAXINE HCL ER 64 19 32 84
CRESTOR 60 48 33 28
TAMSULOSIN HCL 60 46 33 29
KLOR-CON M20 59 45 35 48
PENTOXIFYLLINE 59 55 35 401
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 44 37 27
GLYBURIDE 58 58 R 37 64
PANTOPRAZOLE SODIUM 58 38 37 22
AZITHROMYCIN 57 41 40 38
CIPROFLOXACIN HCL 57 38 40 77
CELEBREX 56 45 42 69
SPIRONOLACTONE 56 38 42 80
PLAVIX 55 49 44 39
CYCLOBENZAPRINE HCL 55 16 R 44 87
FLUTICASONE PROPIONATE 53 38 46 46
TRAZODONE HCL 53 22 46 49
DIOVAN 51 41 48 31
ZOLPIDEM TARTRATE 50 43 49 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.